title: Clinical reversal of multidrug resistance.
authors.affiliation: Stanford University Medical Center, CA 94305.
authors.forename: B I
authors.initials: BI
authors.lastname: Sikic
authors.forename: G A
authors.initials: GA
authors.lastname: Fisher
authors.forename: B L
authors.initials: BL
authors.lastname: Lum
authors.forename: N A
authors.initials: NA
authors.lastname: Brophy
authors.forename: A M
authors.initials: AM
authors.lastname: Yahanda
authors.forename: K M
authors.initials: KM
authors.lastname: Adler
authors.forename: J
authors.initials: J
authors.lastname: Halsey
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D000970:Antineoplastic Agents / Q000494:pharmacology; D001693:Biological Transport, Active / Q000187:drug effects; D002986:Clinical Trials as Topic; D016572:Cyclosporine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use; D015870:Gene Expression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics; D017239:Paclitaxel / Q000494:pharmacology / Q000627:therapeutic use; D004364:Pharmaceutical Preparations / Q000378:metabolism; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D004364:Pharmaceutical Preparations; D005047:Etoposide; D016572:Cyclosporine; D014700:Verapamil; D017239:Paclitaxel